Cogent Biosciences (COGT) Current Leases (2019 - 2026)

Cogent Biosciences' Current Leases history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Current Leases fell 14.15% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 14.15% YoY), while the FY2025 annual figure was $1.5 million, down 1.15% from the prior year.
• Current Leases was $1.4 million for Q1 2026 at Cogent Biosciences, down from $1.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $9.1 million in Q2 2022 to a low of $947000.0 in Q1 2023.
• Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Leases soared 314.7% in 2022, then plunged 87.0% in 2023.
• A 5-year view of Current Leases shows it stood at $1.4 million in 2022, then slipped by 2.6% to $1.4 million in 2023, then rose by 12.91% to $1.6 million in 2024, then decreased by 1.15% to $1.5 million in 2025, then fell by 10.6% to $1.4 million in 2026.
• The last three Current Leases figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.